| Vaccination in post-tuberculosis lung disease management: a review of the evidence MJ Nasiri, DR Silva, F Rommasi, MM Zahmatkesh, Z Tajabadi, ... Pulmonology, 2023 | 5 | 2023 |
| Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review MHND Mohammad Sadegh Fallahi, Nasibeh Zerangian, Atousa Ghorbani, Gisou ... Current Cancer Therapy Reviews, 2023 | | 2023 |
| Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer F Rommasi Scientific Reports 13 (1), 8447, 2023 | 3 | 2023 |
| Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2 MM Javadi, MT Hosseinzadeh, N Soleimani, F Rommasi Microbial Pathogenesis 170, 105687, 2022 | 7 | 2022 |
| Bacterial-based methods for cancer treatment: What we know and where we are F Rommasi Oncology and Therapy 10 (1), 23-54, 2022 | 29 | 2022 |
| COVID-19 in patients with and without acute kidney injury. T Sabaghian, F Rommasi, F Omidi, B Hajikhani, MJ Nasiri, M Mirsaeidi Bratislava Medical Journal/Bratislavske Lekarske Listy 123 (5), 2022 | 4 | 2022 |
| Relationship between blood clots and COVID-19 vaccines: A literature review SMH Atyabi, F Rommasi, MH Ramezani, MF Ghane Ezabadi, MAA Arani, ... Open Life Sciences 17 (1), 401-415, 2022 | 13 | 2022 |
| Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features F Rommasi, MJ Nasiri, M Mirsaeidi Molecular and cellular biochemistry 477 (3), 711-726, 2022 | 22 | 2022 |
| Potential application of Helicobacter pylori against cancer: carcinogenic pathogen or therapeutic agent? N Soleimani, RE Askari, F Rommasi Bratislava Medical Journal/Bratislavske Lekarske Listy 123 (3), 2022 | 1 | 2022 |
| SARS-CoV-2 IgG and IgM Analysis in Patients Who Attended a University Hospital During the COVID-19 Epidemic in Iran F Fayaz, F Rommasi, L Atefmehr, MJ Nasiri Novelty in Biomedicine 10 (4), 226-231, 2022 | | 2022 |
| Cytotoxic Activity of Nisin on Human Cancer Cell Lines: A Systematic Review SS Hosseini, B Hajikhani, H Goudarzi, F Rommasi, MJ Nasiri Novelty in Biomedicine 10 (3), 184-191, 2022 | | 2022 |
| Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data. F Rommasi, MJ Nasiri, M Mirsaiedi European Review for Medical & Pharmacological Sciences 25 (11), 2021 | 9 | 2021 |
| Liposomal nanomedicine: applications for drug delivery in cancer therapy F Rommasi, N Esfandiari Nanoscale Research Letters 16 (1), 95, 2021 | 128 | 2021 |
